Use of proteomics to discover novel markers of cardiac allograft rejection.
Endomyocardial biopsy remains the most reliable method of detecting rejection following cardiac transplantation. Despite numerous attempts to detect rejection using a blood assay, none have proved reliable enough to replace the biopsy. Here, we have investigated the hypothesis that proteomics has th...
Main Authors: | Borozdenkova, S, Westbrook, J, Patel, V, Wait, R, Bolad, I, Burke, M, Bell, A, Banner, N, Dunn, M, Rose, M |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2004
|
Similar Items
-
The role of the macrophage in cardiac allograft rejection in the rat.
by: Macpherson, G, et al.
Published: (1984) -
The novel proteomic signature for cardiac allograft vasculopathy
by: Dongmei Wei, et al.
Published: (2022-04-01) -
A Review of Biomarkers of Cardiac Allograft Rejection: Toward an Integrated Diagnosis of Rejection
by: Guillaume Coutance, et al.
Published: (2022-08-01) -
CHEMOKINE MARKERS ASSOCIATED WITH EARLY REJECTION OF KIDNEY ALLOGRAFT
by: T. V. Fedorenko, et al.
Published: (2019-10-01) -
Identification of gene markers for the prediction of allograft rejection or permanent acceptance.
by: Sawitzki, B, et al.
Published: (2007)